Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity
- PMID: 16220978
- DOI: 10.1021/jm050280z
Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity
Abstract
Two 1,3,5-trisubstituted aromatic scaffolds intended to serve as gamma-turn mimetics have been synthesized and incorporated in five pseudopeptide analogues of angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe), replacing Val-Tyr-Ile, Val-Tyr, or Tyr-Ile. All the tested compounds exhibited nanomolar affinity for the AT2 receptor with the best compound (3) having a K(i) of 1.85 nM. Four pseudopeptides were AT2 selective, while one (5) also exhibited good affinity for the AT1 receptor (K(i) = 30.3 nM). This pseudopeptide exerted full agonistic activity in an AT2 receptor induced neurite outgrowth assay but displayed no agonistic effect in an AT1 receptor functional assay. Molecular modeling, using the program DISCOtech, showed that the high-affinity ligands could interact similarly with the AT2 receptor as other ligands with high affinity for this receptor. A tentative agonist model is proposed for AT2 receptor activation by angiotensin II analogues. We conclude that the 1,3,5-trisubstituted benzene rings can be conveniently prepared and are suitable as gamma-turn mimics.
Similar articles
-
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.J Med Chem. 2006 Oct 5;49(20):6133-7. doi: 10.1021/jm051222g. J Med Chem. 2006. PMID: 17004728
-
New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.J Med Chem. 2005 Jun 16;48(12):4009-24. doi: 10.1021/jm0491492. J Med Chem. 2005. PMID: 15943474
-
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.Bioorg Med Chem. 2006 Sep 1;14(17):5963-72. doi: 10.1016/j.bmc.2006.05.019. Epub 2006 Jun 5. Bioorg Med Chem. 2006. PMID: 16753301
-
Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally.Cardiovasc Res. 2005 Aug 1;67(2):208-15. doi: 10.1016/j.cardiores.2005.04.015. Cardiovasc Res. 2005. PMID: 15953595 Review.
-
Angiotensin Peptides as AT2 Receptor Agonists.Curr Protein Pept Sci. 2017;18(8):809-818. doi: 10.2174/1389203718666170203150344. Curr Protein Pept Sci. 2017. PMID: 28164758 Review.
Cited by
-
Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?Front Endocrinol (Lausanne). 2011 Aug 26;2:17. doi: 10.3389/fendo.2011.00017. eCollection 2011. Front Endocrinol (Lausanne). 2011. PMID: 22649365 Free PMC article.
-
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).J Med Chem. 2018 Feb 8;61(3):918-933. doi: 10.1021/acs.jmedchem.7b01406. Epub 2018 Jan 5. J Med Chem. 2018. PMID: 29240418 Free PMC article.
-
Biomimetic Aerobic C-H Olefination of Cyclic Enaminones at Room Temperature: Development toward the Synthesis of 1,3,5-Trisubstituted Benzenes.Adv Synth Catal. 2014 Apr 14;356(6):1359-1369. doi: 10.1002/adsc.201300904. Adv Synth Catal. 2014. PMID: 25071423 Free PMC article.
-
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.Biomolecules. 2020 Apr 23;10(4):649. doi: 10.3390/biom10040649. Biomolecules. 2020. PMID: 32340100 Free PMC article.
-
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281. Pharmacol Rev. 2022. PMID: 36180112 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Research Materials